N/A N=56 Total Knee Arthroplasty: Comparison of Fixed and Mobile Bearings
Knee Osteoarthritis
Primary: Gait Stride Length — 1.2; 1.2 meters — p=0.05
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=20 Medium Chain Triglycerides and Aerobic Exercise on Ketone Production in Women With or Without Prediabetes
Prediabetic State
Primary: Plasma Ketone Concentrations — -52; 12; 493; 627 (µmol/h)/L
N/A N=1,622 Patient Journey in Hospital With Heart Failure in Turkish Population
Heart Failure
Primary: Adherence to European Heart Failure Guideline — 1172 Participants
N/A N=96 Polyethylene Wear Study on the Triathlon Total Knee Prosthesis
Arthroplasty, Replacement, Knee
Primary: Assessment of Polyethylene Inlay Wear by Roentgen Stereophotogrammetric Analysis (RSA). — -0.08; -0.03; 0.22; 0.22 mm
N/A N=2,446 Prospective Observational Epidemiologic Study of Maraviroc's Safety
Human Immunodeficiency Virus
Primary: Density Rate Per 1000 Participant-Years for Incidence of Centers for Disease Control and Prevention Category C AIDS -Defining Opportunistic Infections — 22.28; 41.77…
Phase 4 N=30 A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.
Heart Failure (HF)
Primary: Change From Baseline in Heart Rate (HR) at Day 57 — -9.5 beats per minute — p=0.013
N/A N=48 Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA
Cerebrovascular Accident (CVA) · Stroke · Hemiplegia
Primary: Safety of Individuals With Hemiplegia Due to CVA Using the Indego Measured Through Reported Subject Adverse Events and Serious Adverse Events — 3; 0 Events
N/A N=97 Multifactorial Treatment of Cardiovascular Risk in Diabetic Patients: Identification of Treatment Non-Responders
Diabetes Mellitus, Type II
Primary: Change of Intima Media Thickness (IMT) — -0.023 mm — p=0.021
Phase 4 N=56 Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD
Attention Deficit Hyperactivity Disorder
Primary: Rule Violations During Direct Classroom Observation at Endpoint (Week 8) — 6.15; 4.93 number occurences per 30 mins — p=<.05
Phase 2 N=174 Phase 2B Study of PTC124 (Ataluren) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
Duchenne Muscular Dystrophy · Becker Muscular Dystrophy
Primary: Change From Baseline in 6MWD at Week 48 — -41.81; -12.86; -42.56 meters — p=0.4756
N/A N=42 The Use of Bellafill for Atrophic Acne Scar Correction in the Full Facial Area
Atrophic Acne Scarring
Primary: Change on the Acne Scar Assessment Scale (ASAS) — 3.33; 2.19; 2.20 units on a scale
Phase 4 N=46 Evaluation of Systane Complete for the Treatment of Contact Lens Discomfort
Contact Lens Discomfort · Dry Eye
Primary: Contact Lens Symptoms — 20.41; 18.92; 12.86; 17.92 Score on a Scale
Phase 3 N=64 Effects of Acthar on Recovery From Cognitive Relapses in MS
Multiple Sclerosis
Primary: Change From Baseline on the Symbol Digit Modalities Test (SDMT) — 44.6; 58.5 Total Correct
N/A N=164 Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)
Venous Leg Ulcers · Diabetic Foot Ulcers
Primary: Change in Ulcer Area From Baseline to the End of the Treatment Period — 6.2; 7.8; 0.7; 3.8 cm^2 — p=0.001
N/A N=516 Clinical Utility Study of a Low-Cost Hand-Held Breast Scanner
Breast Cancer
Primary: Compare the Outcomes of the iBE Examinations to Clinical Breast Examinations (CBE)by Estimating the Sensitivity of the Device Using Imaging Results — 34.3 percentage of…